Neonatal fatty acid status and neurodevelopmental outcome at 9 years

Corina de Jong, Hedwig K. Kikkert, Jorien Seggers, Gunther Boehm, T. Decsi, Mijna Hadders-Algra

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Long-chain polyunsaturated fatty acids (LCPUFA) are important for prenatal brain development. Previous studies of others assessed outcome until 7. years. The associations between neonatal LCPUFA status and long-term developmental outcome are debated. Aim: To investigate the relationship between fatty acid status at birth and neurodevelopment at 9. years. Age 9 is a unique age after a significant neurodevelopmental transition. Study design: Correlation study. Multivariable analyses were carried out to adjust for potential confounders. Subjects: 317 children who participated in a trial on effects of postnatal LCPUFA supplementation were eligible. 235 children (74%) were reassessed at age 9. Outcome measures: At birth, docosahexaenoic acid (DHA) and arachidonic acid (AA) were determined in the wall of the umbilical vein. We primarily studied the correlation between DHA and AA with the complex form of minor neurological dysfunction (cMND). Secondary correlations that were studied were DHA and AA levels with cognitive development in terms of full IQ, and with behavioural development in terms of a total problem score. Results: Boys with cMND showed lower DHA values in the umbilical vein than children with better neurological condition (p. =. 0.033). A similar association was absent in girls. Neonatal AA values were not associated with neurological outcome. Neither neonatal DHA nor AA values were associated with cognition and behaviour at 9. Conclusions: Higher umbilical DHA levels in boys are associated with better neurological development at 9. years. AA status at birth was not associated with neurodevelopment at 9. years.

Original languageEnglish
Pages (from-to)587-591
Number of pages5
JournalEarly Human Development
Volume91
Issue number10
DOIs
Publication statusPublished - Oct 1 2015

Fingerprint

Docosahexaenoic Acids
Arachidonic Acid
Fatty Acids
Unsaturated Fatty Acids
Umbilical Veins
Parturition
Umbilicus
Cognition
Outcome Assessment (Health Care)
Brain

Keywords

  • Fatty acids
  • LCPUFA
  • Minor neurological dysfunction
  • Neurodevelopment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

de Jong, C., Kikkert, H. K., Seggers, J., Boehm, G., Decsi, T., & Hadders-Algra, M. (2015). Neonatal fatty acid status and neurodevelopmental outcome at 9 years. Early Human Development, 91(10), 587-591. https://doi.org/10.1016/j.earlhumdev.2015.07.007

Neonatal fatty acid status and neurodevelopmental outcome at 9 years. / de Jong, Corina; Kikkert, Hedwig K.; Seggers, Jorien; Boehm, Gunther; Decsi, T.; Hadders-Algra, Mijna.

In: Early Human Development, Vol. 91, No. 10, 01.10.2015, p. 587-591.

Research output: Contribution to journalArticle

de Jong, C, Kikkert, HK, Seggers, J, Boehm, G, Decsi, T & Hadders-Algra, M 2015, 'Neonatal fatty acid status and neurodevelopmental outcome at 9 years', Early Human Development, vol. 91, no. 10, pp. 587-591. https://doi.org/10.1016/j.earlhumdev.2015.07.007
de Jong, Corina ; Kikkert, Hedwig K. ; Seggers, Jorien ; Boehm, Gunther ; Decsi, T. ; Hadders-Algra, Mijna. / Neonatal fatty acid status and neurodevelopmental outcome at 9 years. In: Early Human Development. 2015 ; Vol. 91, No. 10. pp. 587-591.
@article{6682180218054d099451024b8350741a,
title = "Neonatal fatty acid status and neurodevelopmental outcome at 9 years",
abstract = "Background: Long-chain polyunsaturated fatty acids (LCPUFA) are important for prenatal brain development. Previous studies of others assessed outcome until 7. years. The associations between neonatal LCPUFA status and long-term developmental outcome are debated. Aim: To investigate the relationship between fatty acid status at birth and neurodevelopment at 9. years. Age 9 is a unique age after a significant neurodevelopmental transition. Study design: Correlation study. Multivariable analyses were carried out to adjust for potential confounders. Subjects: 317 children who participated in a trial on effects of postnatal LCPUFA supplementation were eligible. 235 children (74{\%}) were reassessed at age 9. Outcome measures: At birth, docosahexaenoic acid (DHA) and arachidonic acid (AA) were determined in the wall of the umbilical vein. We primarily studied the correlation between DHA and AA with the complex form of minor neurological dysfunction (cMND). Secondary correlations that were studied were DHA and AA levels with cognitive development in terms of full IQ, and with behavioural development in terms of a total problem score. Results: Boys with cMND showed lower DHA values in the umbilical vein than children with better neurological condition (p. =. 0.033). A similar association was absent in girls. Neonatal AA values were not associated with neurological outcome. Neither neonatal DHA nor AA values were associated with cognition and behaviour at 9. Conclusions: Higher umbilical DHA levels in boys are associated with better neurological development at 9. years. AA status at birth was not associated with neurodevelopment at 9. years.",
keywords = "Fatty acids, LCPUFA, Minor neurological dysfunction, Neurodevelopment",
author = "{de Jong}, Corina and Kikkert, {Hedwig K.} and Jorien Seggers and Gunther Boehm and T. Decsi and Mijna Hadders-Algra",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.earlhumdev.2015.07.007",
language = "English",
volume = "91",
pages = "587--591",
journal = "Early Human Development",
issn = "0378-3782",
publisher = "Elsevier Ireland Ltd",
number = "10",

}

TY - JOUR

T1 - Neonatal fatty acid status and neurodevelopmental outcome at 9 years

AU - de Jong, Corina

AU - Kikkert, Hedwig K.

AU - Seggers, Jorien

AU - Boehm, Gunther

AU - Decsi, T.

AU - Hadders-Algra, Mijna

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: Long-chain polyunsaturated fatty acids (LCPUFA) are important for prenatal brain development. Previous studies of others assessed outcome until 7. years. The associations between neonatal LCPUFA status and long-term developmental outcome are debated. Aim: To investigate the relationship between fatty acid status at birth and neurodevelopment at 9. years. Age 9 is a unique age after a significant neurodevelopmental transition. Study design: Correlation study. Multivariable analyses were carried out to adjust for potential confounders. Subjects: 317 children who participated in a trial on effects of postnatal LCPUFA supplementation were eligible. 235 children (74%) were reassessed at age 9. Outcome measures: At birth, docosahexaenoic acid (DHA) and arachidonic acid (AA) were determined in the wall of the umbilical vein. We primarily studied the correlation between DHA and AA with the complex form of minor neurological dysfunction (cMND). Secondary correlations that were studied were DHA and AA levels with cognitive development in terms of full IQ, and with behavioural development in terms of a total problem score. Results: Boys with cMND showed lower DHA values in the umbilical vein than children with better neurological condition (p. =. 0.033). A similar association was absent in girls. Neonatal AA values were not associated with neurological outcome. Neither neonatal DHA nor AA values were associated with cognition and behaviour at 9. Conclusions: Higher umbilical DHA levels in boys are associated with better neurological development at 9. years. AA status at birth was not associated with neurodevelopment at 9. years.

AB - Background: Long-chain polyunsaturated fatty acids (LCPUFA) are important for prenatal brain development. Previous studies of others assessed outcome until 7. years. The associations between neonatal LCPUFA status and long-term developmental outcome are debated. Aim: To investigate the relationship between fatty acid status at birth and neurodevelopment at 9. years. Age 9 is a unique age after a significant neurodevelopmental transition. Study design: Correlation study. Multivariable analyses were carried out to adjust for potential confounders. Subjects: 317 children who participated in a trial on effects of postnatal LCPUFA supplementation were eligible. 235 children (74%) were reassessed at age 9. Outcome measures: At birth, docosahexaenoic acid (DHA) and arachidonic acid (AA) were determined in the wall of the umbilical vein. We primarily studied the correlation between DHA and AA with the complex form of minor neurological dysfunction (cMND). Secondary correlations that were studied were DHA and AA levels with cognitive development in terms of full IQ, and with behavioural development in terms of a total problem score. Results: Boys with cMND showed lower DHA values in the umbilical vein than children with better neurological condition (p. =. 0.033). A similar association was absent in girls. Neonatal AA values were not associated with neurological outcome. Neither neonatal DHA nor AA values were associated with cognition and behaviour at 9. Conclusions: Higher umbilical DHA levels in boys are associated with better neurological development at 9. years. AA status at birth was not associated with neurodevelopment at 9. years.

KW - Fatty acids

KW - LCPUFA

KW - Minor neurological dysfunction

KW - Neurodevelopment

UR - http://www.scopus.com/inward/record.url?scp=84942525203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942525203&partnerID=8YFLogxK

U2 - 10.1016/j.earlhumdev.2015.07.007

DO - 10.1016/j.earlhumdev.2015.07.007

M3 - Article

C2 - 26231619

AN - SCOPUS:84942525203

VL - 91

SP - 587

EP - 591

JO - Early Human Development

JF - Early Human Development

SN - 0378-3782

IS - 10

ER -